Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9302757rdf:typepubmed:Citationlld:pubmed
pubmed-article:9302757lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:9302757lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:9302757lifeskim:mentionsumls-concept:C0042196lld:lifeskim
pubmed-article:9302757lifeskim:mentionsumls-concept:C0150647lld:lifeskim
pubmed-article:9302757lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9302757lifeskim:mentionsumls-concept:C0579250lld:lifeskim
pubmed-article:9302757pubmed:issue12-13lld:pubmed
pubmed-article:9302757pubmed:dateCreated1997-10-23lld:pubmed
pubmed-article:9302757pubmed:abstractTextA commercial killed Leptospira hardjo vaccine (with adjuvant) and non-adjuvanted preparation of the same vaccine were used in comparison of the effectiveness of the intradermal (i.d.) and subcutaneous (s.c.) routes for these vaccines. The tests were conducted in 50 females aged 6-14 months. After the first vaccination, both types of vaccine elicited a very poor antibody response by both routes of vaccination. However, after booster vaccination, the commercial vaccine (with adjuvant) elicited a remarkable immune response which was twice as high by i.d. compared with s.c. vaccination. No local or general adverse reactions were observed after i.d. vaccination with the adjuvanted commercial vaccine (potassium aluminium sulphate).lld:pubmed
pubmed-article:9302757pubmed:languageenglld:pubmed
pubmed-article:9302757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9302757pubmed:citationSubsetIMlld:pubmed
pubmed-article:9302757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9302757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9302757pubmed:statusMEDLINElld:pubmed
pubmed-article:9302757pubmed:issn0264-410Xlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:CohenAAlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:SamimyBBlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:BrennerJJlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:PelegB ABAlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:BerensteinMMlld:pubmed
pubmed-article:9302757pubmed:authorpubmed-author:MoalemUUlld:pubmed
pubmed-article:9302757pubmed:issnTypePrintlld:pubmed
pubmed-article:9302757pubmed:volume15lld:pubmed
pubmed-article:9302757pubmed:ownerNLMlld:pubmed
pubmed-article:9302757pubmed:authorsCompleteYlld:pubmed
pubmed-article:9302757pubmed:pagination1434-6lld:pubmed
pubmed-article:9302757pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:meshHeadingpubmed-meshheading:9302757-...lld:pubmed
pubmed-article:9302757pubmed:articleTitleEnhanced antibody response in cattle against Leptospira hardjo by intradermal vaccination.lld:pubmed
pubmed-article:9302757pubmed:affiliationState Laboratory for Vaccine Control, Kimou Veterinary Institute, Bet Dagan, Israel.lld:pubmed
pubmed-article:9302757pubmed:publicationTypeJournal Articlelld:pubmed